Leah Frye
Keine laufenden Positionen mehr
Profil
Leah Frye worked as a Principal Scientist at Boehringer Ingelheim Pharmaceuticals, Inc. and as a Vice President-Drug Discovery Applications Group at Schrödinger, Inc. She earned a doctorate degree from The Johns Hopkins University in 1984.
Ehemalige bekannte Positionen von Leah Frye
Unternehmen | Position | Ende |
---|---|---|
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Corporate Officer/Principal | - |
SCHRÖDINGER, INC. | Corporate Officer/Principal | - |
Ausbildung von Leah Frye
The Johns Hopkins University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SCHRÖDINGER, INC. | Technology Services |
Private Unternehmen | 1 |
---|---|
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Health Technology |